The decision is usually framed as a choice between a cheaper route plus a better one. That framing costs money, because the two routes are not competing answers to the same question. Taking an existing formula buys speed plus a shorter risk list. Commissioning a formula buys a position no competitor can copy. A brand that does not know which of those two things it needs will pay for one plus receive the other.
This article sets out both routes from the manufacturing side: what an existing formula covers in practice, what a development project actually involves, where the weeks plus the money go in each, how exclusivity plus ownership are negotiated, what happens to a bespoke formula when the rules change, when development earns its cost, plus the hybrid route most brands end up on without naming it. By the end you should be able to write a brief that states which route you want plus why.
The real question behind existing formula versus new development
There are only two reasons to commission a formula. The first is that the product has to do something the existing options cannot do: a texture, a sensory result, a format behaviour or an ingredient position that no available base delivers. The second is that the brand needs a position it can defend, meaning the fill is not available to anyone else who asks the same factory.
Everything else is answered by an existing formula. A moisturiser that moisturises, a cleanser that cleanses plus a body lotion that spreads well are all solved problems, plus a proven base solves them with stability plus preservation work already completed. Paying for development to reach the same functional result buys nothing except a longer timeline plus a larger first order.
The clean way to make the decision is to separate the requirement into two lists. The performance list is what the product has to do. The identity list is what has to be unmistakably yours. Where the performance list is ordinary plus the identity list is carried by the pack, the scent plus the story, the existing route wins. Where the identity lives inside the fill, development is the only route that delivers it.
What an existing formula covers: three different arrangements
The first arrangement is a factory base bought as-is with the brand's name on the pack, usually described as private label. The formula stays with the plant, it may be offered to other customers, plus the brand's protection sits in the pack plus the market position rather than in the formula. It is the fastest route plus the cheapest, plus its weakness is obvious: the same fill can appear under another name.
The second arrangement is a licensed formula, where use rights are granted under an agreement that defines the scope. The scope is where the value sits, plus it usually covers a category, a market or a period rather than everything. A licence can be exclusive or non-exclusive, it can be limited to one channel, plus it usually sits with the licensor rather than passing to the brand. What it buys is a formula that already exists plus a set of rights around it.
The third arrangement is a base adopted plus modified under the brand's instruction, which the industry often calls hybrid or semi-custom. The plant starts from something it has already made plus changes a defined part of it: the fragrance, the texture target, an emollient system, a colour. It is the cheapest way to reach a fill that is not generally available, plus it is a development project with a shorter runway rather than an off-the-shelf purchase.
What commissioning a formula involves, step by step
Development starts with a brief a formulator can work from, which is a document about behaviour rather than about ingredients. How it should feel on application, how quickly it should absorb, how it should look in the pack, what the customer should notice after one use, plus which claims the wording will need to carry. A brief written entirely in ingredient names narrows the formulation space before the formulator has started.
The second step is a prototype round, usually two or three versions presented together so the brand can compare rather than approve or reject one. Each version is assessed on texture, on stability behaviour plus on compatibility with the intended pack. A version that feels right but separates in a warm cabinet is not a candidate, plus the assessment has to happen before the brand falls in love with a sample.
The third step is the work that sits behind the sample. Preservation challenge against the intended pack, stability under accelerated plus where needed real-time conditions, packaging compatibility in the actual bottle or tube with the actual closure, plus any testing the intended wording requires. This is the part of a development project that brands underestimate, plus it is the part that cannot be compressed by asking for it sooner.
The fourth step is industrialisation: scaling the chosen version from a laboratory batch to a production batch, confirming the process parameters plus fixing the specification. A formula that behaves perfectly at small scale can thicken differently in a production tank, plus the settings that produce the same result at scale are part of the deliverable rather than an afterthought.
Where the weeks actually go in each route
On an existing formula, the long pole is usually not the fill at all. It is the pack. Artwork approval, print plus component lead times sit on the critical path, plus the fill itself can be booked once the pack position is known. A brand that has already decided its pack plus its artwork can move from brief to a first batch quickly, because the formula carries no open questions.
On a commissioned formula, the timeline is dominated by the testing that sits behind the claims plus the shelf life. Sampling plus the prototype round is a fast part. The stability plus preservation programme is the slow part, plus it runs in parallel with packaging compatibility rather than before it. The sequence that saves the most time is to test the chosen prototype in the real pack from the first round, rather than testing in glass plus repeating everything later.
On the hybrid route, the timeline is closer to the existing route plus one testing cycle. Changing a fragrance or a texture target inside an established formula still requires stability plus compatibility work, because the change touches the system even when the base does not move. What it does not require is a fresh formulation programme, plus that is where the weeks are saved.
What you pay for, plus at which stage
An existing formula carries no development fee in most cases, because the work has already been paid for across earlier orders. What the brand pays for is the fill at the production price plus, usually, a one-off charge for sampling plus the artwork-related items. The entry cost is dominated by the pack minimum rather than by the formula.
A licensed formula is priced differently. There may be an upfront fee for the rights, a royalty or a per-unit element, plus a defined scope that limits where the product can be sold. A brand comparing a licence against a development project needs to compare the total cost across the expected volume, not the first invoice, because a per-unit element grows while a development fee does not.
A commissioned formula is priced as work. The development fee covers the prototype rounds, the formulation time plus the testing programme, plus it is normally staged: an amount at brief, an amount at prototype approval plus the balance before the stability programme concludes. The finished unit then carries a production price like any other fill, plus the development fee does not repeat on later orders. The mistake is reading the development fee as the whole cost; the real cost is the fee plus the longer timeline plus the larger minimum that a new formula can bring with it.
Exclusivity plus ownership: the clause that decides the project
Ownership plus exclusivity are separate questions plus they are negotiated separately. Ownership asks who holds the formula itself. Exclusivity asks who is entitled to buy products made from it. A brand can own a formula plus still see it sold to others if the agreement allows it, plus a brand can own nothing plus hold a firm exclusivity on one category plus one market.
Where a brand commissions development, the ownership term should say what happens at the end of the relationship. Can the formula be moved to another plant? Does the brand receive the formulation document, or only the right to keep buying the finished product? A brand that intends to regard the formula as an asset needs the document plus the freedom to have it produced elsewhere, plus those are two different clauses.
Where the route is an existing or licensed formula, exclusivity is normally scoped rather than absolute. A term that reserves a formula plus a pack plus a category plus a market for a defined period is workable. A demand for global exclusion across every category is usually refused, plus a brand that raises it after the sampling has begun finds the price has moved. The time to describe the scope is in the brief.
Reformulation risk plus regulatory change
An ingredient restriction, a labelling change or a limit tightened in a destination market can force a formula to be revisited regardless of who owns it. The difference between the routes is who carries the work plus how fast it can be done. Where the formula is a proven factory base, the plant usually already has alternatives plus an internal record of what can be substituted safely.
Where the formula is bespoke plus owned by the brand, the change may mean returning to the original developer, or to whichever party holds the formulation document. That is a contract question, plus it is worth answering before the change arrives rather than during it. A brand that cannot instruct anyone to reformulate its own product is dependent on a supplier relationship it may not want to keep.
There is also a reformulation risk that has nothing to do with regulation: a raw material that becomes unavailable, or a supplier that changes a specification. Both routes meet this, plus both are managed the same way, by keeping a specification plus a second qualified source for the materials that matter. What the brand should know in advance is which materials in its formula are single-sourced, plus who is responsible for finding a replacement.
When bespoke development earns its cost
Development earns its cost when the fill is the visible difference. A texture that cannot be bought off the shelf, a delivery format that no existing base supports, an ingredient combination that carries a specific position in the market. Those are differences a customer can feel plus a competitor cannot copy quickly, plus they justify the fee, the timeline plus the minimum.
Development also earns its cost when the brand intends to sell the formula as an asset. Where a brand is building a brand rather than a product listing, owning a formula that no other customer of the same plant can buy is part of the valuation. That is a commercial argument rather than a technical one, plus it belongs in the decision.
Development does not earn its cost when the difference will be carried by the pack, the scent plus the copy. A customer buying a facial serum largely responds to the texture plus the result, plus both of those can be delivered by a modified base. Paying for a full development programme in a category where several proven fills already work is one of the commonest ways a first order becomes unaffordable.
The hybrid route most brands end up on
Most brands that ask about development actually want a modified base, plus naming that in the brief shortens the project considerably. A hybrid project changes a defined part of an established formula, which means the base carries its stability history plus the new element carries its own testing. The result is a fill that is not generally available plus a timeline closer to a private label order.
The hybrid route is also the natural second step. A brand can launch on a proven base, learn what customers respond to, plus move one item to a modified or bespoke formula once the price point plus the volume are known. That sequence puts the development spend after the market evidence rather than before it, which is the opposite of how these projects usually run.
The brief is what makes the hybrid possible. A brand that asks for an existing formula gets one, plus a brand that asks for full development gets a quotation for full development. A brand that describes the exact part of the formula it wants changed, plus what it is willing to leave alone, gets the cheaper route without having to negotiate for it.
Comparing the two routes side by side
The table below compares the routes across the points where they actually differ. It is written for a brand deciding what to ask for, plus it sets out what each route gives you plus what it leaves open.
| Point | Existing or licensed formula | Commissioned formula | What this means for the first order |
|---|---|---|---|
| Time to first batch | Limited mainly by pack plus artwork lead time | Includes a prototype round plus a testing programme | The pack is the critical path either way, so decide it early |
| Development fee | None in most cases, or a licence fee for the rights | Staged fee across brief, prototype plus testing | The fee does not repeat on later orders, the pack minimum does |
| Stability plus preservation | Already completed for the base | Carried out for the new formulation | The testing window cannot be shortened by paying more |
| Exclusivity | Scope must be agreed, often category or market limited | Can be exclusive if the contract says so | Ask for the scope in the brief, not after sampling |
| Ownership of the document | Usually retained by the plant or the licensor | Negotiable, plus it decides whether the formula is an asset | State whether you intend to produce it elsewhere later |
| Ability to move plant | Restricted, since the basis stays with the holder | Possible where the document plus the rights transfer | Dependency is a commercial term, not a technical one |
| Response to a rule change | Handled by the plant inside its existing base | Depends on who can instruct a reformulation | Agree who is responsible before the change arrives |
| Fit for a distinctive position | Carried by pack, scent plus story | Carried by the fill itself | Decide whether the difference must be felt or only seen |
Read this as a relative comparison rather than a fixed set of terms. Lead times, fees plus scopes move with the plant, the category, the market plus the volume, plus many projects combine two routes across different items in the same range. The table is a way to frame the question you put to a supplier, not a substitute for the answer.
What to put in the brief
Say which route you are asking for plus what you are willing to leave open. A brief that states a requirement plus a budget plus a launch window gives a formulator room to propose the cheapest route to the result, instead of quoting the most expensive one that satisfies the words.
- The behaviour you need: how it should feel, absorb, look plus behave in the pack.
- Which parts of the formula are yours to decide plus which parts you will accept as they are.
- Whether the fill itself has to be distinctive, or whether the pack plus the scent carry the position.
- The markets you will sell in, since the permitted ingredient lists plus the labelling duties differ.
- The exclusivity scope you want, described by category, market plus period rather than as a general request.
- Whether you intend to own the formulation document plus to be able to produce it elsewhere.
- The claim wording you want to use, so feasibility is checked before the testing programme is designed.
- The quantity plus the money available for the first order, distinct from the volume you hope to reach later.
Then ask for the route to be quoted both ways where it matters. A supplier who prices the existing or hybrid option plus the full development option beside each other has told you what the difference costs, plus that number is the one to weigh against the value of a position only you can hold.
Where our capability fits
We quote the three routes separately, an existing base, a base modified to a defined part of the brief plus a full development programme, so the difference in fee, timeline plus minimum is visible before a route is chosen. Where a brief can be met by modifying a base we already run, we say so rather than quoting development, plus where exclusivity can or cannot be granted we answer that in writing at the brief stage.
We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing & full custom formula development, plus the same plant carries a product from a proven base through to a bespoke formula as the range develops. Our lines include a ceramide facial essence capsule & a vitamin C face cream, which are the kind of proven bases a modified route can start from.
Tell us the behaviour you need, the markets you are selling into plus whether the fill has to be yours alone, plus we will come back with what an existing base covers, what a modified base would change plus what a development programme would add. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319. The difference between the two private label routes is set out in our comparison of private label plus custom formula, the middle route in our note on hybrid ODM, plus the development sequence itself in our guide from brief to production.
General manufacturing information, not regulatory or legal advice. Development fees, exclusivity terms, ownership of formulations, testing requirements plus permitted ingredient lists vary by plant, by market plus by contract, so the applicable terms should be confirmed in writing plus reviewed with a qualified adviser before a product is placed on sale.